BMY
Price
$58.81
Change
-$2.34 (-3.83%)
Updated
Oct 5, 04:59 PM (EDT)
Capitalization
130.49B
24 days until earnings call
Intraday BUY SELL Signals
XLV
Price
$167.42
Change
+$1.24 (+0.75%)
Updated
Oct 5, 04:59 PM (EDT)
Net Assets
43.92B
Intraday BUY SELL Signals
Interact to see
Advertisement

BMY vs XLV

BMY vs XLV Comparison Chart in %
View a ticker or compare two or three
VS
BMY vs. XLV commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Hold and XLV is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BMY: Fundamental Ratings
BMY
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMYXLV
RSI
ODDS (%)
Bullish Trend 4 days ago
47%
Bearish Trend 8 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 6 days ago
45%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
56%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
53%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 4 days ago
84%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (BMY: $61.15)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green while .

  • BMY’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish.

  • BMY’s TA Score: 4 bullish, 6 bearish.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -1.71% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.10%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +8.15%.

Reported Earning Dates

BMY is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-4.10% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
BMY
Daily Signal:
Gain/Loss:
XLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONC358.07-0.70
-0.20%
BeOne Medicines Ltd
PSN40.79-0.22
-0.54%
Parsons Corp
HPK7.85-0.09
-1.13%
HighPeak Energy
FOCL4.20-0.12
-2.78%
Edap TMS SA
CLRB1.78-0.09
-4.81%
Cellectar Biosciences Inc

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with AMGN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
+0.53%
AMGN - BMY
57%
Loosely correlated
-1.04%
PFE - BMY
57%
Loosely correlated
-1.14%
GSK - BMY
53%
Loosely correlated
-0.32%
ABBV - BMY
51%
Loosely correlated
+1.11%
NVS - BMY
51%
Loosely correlated
-0.04%
More

XLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLV
1D Price
Change %
XLV100%
-0.01%
LLY - XLV
74%
Closely correlated
-0.61%
MRK - XLV
68%
Closely correlated
+0.34%
ABBV - XLV
63%
Loosely correlated
+1.11%
JNJ - XLV
62%
Loosely correlated
-1.02%
BMY - XLV
60%
Loosely correlated
+0.53%
More